Phase 2 Study to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INIM Study
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs Inecalcitol (Primary) ; Imatinib
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms INIM study
- Sponsors Hybrigenics
- 12 May 2017 According to a Hybrigenics media release, the company presented encouraging initial results for inecalcitol in combination with oral imatinib in chronic myeloid leukaemia.
- 22 Apr 2015 New trial record
- 20 Apr 2015 This trial was initiated in January 2015, according to a Hybrigenics media release.